ArticleBMC cardiovascular disorders2025
Quality of life and its associated factors in patients with severe aortic stenosis undergoing transapical transcatheter aortic valve replacement: a cross-sectional study.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSevere aortic stenosis (AS) significantly impacts patients' quality of life (QoL). Although transcatheter aortic valve replacement (TAVR) has emerged as a less invasive treatment option, its effects on QoL and associated factors remain inadequately explored. To evaluate QoL and its associated factors in patients with AS following TAVR.
methodsThis cross-sectional study enrolled patients aged 25 years and older who underwent TAVR via transfemoral, transapical, or carotid artery approaches between January 2024 and February 2024. QoL was measured via the validated Chinese Cardiovascular Patients QoL Assessment Questionnaire. Clinical, demographic, and behavioral data were collected through structured interviews and medical record review. Stepwise multiple linear regression analysis was performed to identify predictors of QoL across total and domain-specific scores.
resultsA total of 102 patients were included, with 56.86% aged 71-80 years and 59.80% male. The majority of patients underwent TAVR via the transapical approach (87.25%). Hospital stay duration, medication adherence, and the age-adjusted Charlson Comorbidity Index (Age-CCI) score were identified as significant predictors of total QoL. Specifically, longer hospital stays and higher Age-CCI scores were negatively associated with QoL, whereas good medication adherence was positively associated with QoL. Additionally, regular physical exercise and hospital stay duration emerged as significant predictors across several QoL domains.
conclusionQoL following TAVR is influenced by both clinical and behavioral factors, including hospital stay length, medication adherence, and comorbidity burden. Targeted interventions addressing these modifiable factors may enhance patient recovery and improve long-term QoL outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.